Rothamsted spin-out SugaROx lands £2.5M from Mosaic for crop biostimulant tech
What's the deal? SugaROx, a spin-out from the UK's Rothamsted Research, has secured a £2.5M strategic investment from The Mosaic Company, one of the world's largest crop nutrition firms. The funding will help SugaROx advance its biostimulant technology designed to boost crop health and yields.
Rothamsted Research is one of the oldest agricultural research institutions in the world, and SugaROx is commercialising science developed in its labs.
Why now? The global biostimulants market is growing fast as farmers seek alternatives to traditional chemical inputs amid tightening regulations and rising sustainability pressures. For Mosaic, a strategic bet on biostimulant tech complements its core fertiliser business and positions it in a high-growth adjacent market.
What could go wrong? Biostimulants remain a relatively young product category, and regulatory frameworks vary widely across markets. Proving consistent field-level efficacy at scale is a persistent challenge for startups in this space, and competition from both agchem incumbents and other startups is intensifying.
The signal: Big ag companies are increasingly backing early-stage biotech spin-outs to secure access to next-generation crop science. The deal reflects a broader trend of corporate strategic capital flowing into agritech — particularly biological solutions — as the industry moves toward more sustainable farming systems.
Read more: rothamsted.ac.uk
